Rossari Biotech Q2 FY26 Earnings Surge

  Published 7 months ago

Rossari Biotech's Q2 FY26 revenue rose 17.61% to Rs 586.11 crore, PBT up 3.24% yearly.

  • Expenses surged 19.33% YoY, driven by material costs up 25.54% and finance costs soaring significantly.
  • Half-year net profit marginally increased 0.34% to Rs 70.47 crore, and revenue grew 14.35% in 2025.
  • The board approved up to $8 million investment in Rossari International to boost manufacturing, trading activities strategically.

You might like these

Germany Seeks EU Funding for AI Data Center

Tesla Spain Sales Rise 60.7% in June Amid EV Growth

Titagarh Wins Rs 1,598 Cr Metro Order

India Ready If Russian Oil Hit

Emcure Pharma Gains on JM Buy Call

Sonata Software Q1 Revenue Rises 17%

Vodafone Idea AGR Hearing Set for Oct 27

News that matters the most ⚡